Defending pharmacies caught in CoverMyMeds FWA crackdowns.
CoverMyMeds, McKesson's prior-authorization platform, sits behind the PA workflow of every major PBM, and its FWA crackdown has become one of the most aggressive audit pipelines in pharmacy. A single flagged account pattern can trigger six- and seven-figure recoupments, termination for cause, and parallel audit notices from Express Scripts, OptumRx, and CVS Caremark at once. We defend pharmacies nationwide before the audits close. Every day of delay changes your settlement posture.
.png)
By the time a CoverMyMeds-driven PBM notice arrives, the downstream cross-PBM exposure is already stacked. Here is what your pharmacy is actually defending against.
CoverMyMeds-driven PBM audit findings routinely demand recoupments of $250K to $4M+ per matter, with audit teams aggressively extrapolating a sampled-claim error rate across 12 to 24 months of total dispensing. Defense requires challenging both the sampled findings and the extrapolation methodology.
A termination for cause citing CoverMyMeds account findings rarely stays with one network. Because every major PBM (Express Scripts, OptumRx, CVS Caremark, Humana, Prime) runs prior-auth queues through the McKesson-owned platform, the same account-level finding surfaces in each network's credentialing review. Credentialing impact across multiple payors typically lands within 30 days of the first termination notice.
CoverMyMeds-driven PBM audit findings on controlled substances, compounding, and high-cost specialty claims are routinely referred to DEA, DOJ, HHS-OIG, and state boards of pharmacy. A PBM finding can become a civil investigative demand, a state board complaint, or a federal healthcare fraud investigation within weeks.
Four factors make CoverMyMeds FWA matters uniquely dangerous, and uniquely defensible if you know how the McKesson-owned platform interacts with PBM audit teams.
Our bench includes a former Assistant U.S. Attorney (DOJ Director's Award recipient) and senior PBM operational counsel. We have run more than 2,000 audits across the major PBMs, including CoverMyMeds-mediated PA matters at Express Scripts, OptumRx, and CVS Caremark. This is how we dismantle a CoverMyMeds-driven audit.
Within 24 hours: parse every deadline in the CoverMyMeds-driven PBM audit notice, place a litigation hold on the claims at issue, and preserve the full CoverMyMeds account audit trail and adjudication logs before the PBM evidentiary window narrows.
Claim-by-claim reconstruction: prescriber PA rationale, plan criteria at time of fill, DAW code support, signature log validation, and controlled substance recordkeeping. Every flagged PA gets its own defense memo tied to the CoverMyMeds account record and the PBM citation.
We draft and file the written PBM appeal, quantify the extrapolation errors, and negotiate directly with the PBM audit team while addressing the CoverMyMeds account-level remediation that the platform itself requires.
If the PBM refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, HHS-OIG, and the state board so a PBM dispute does not escalate into a license action or a criminal referral.
If any of these describe your 2024 to 2026 CoverMyMeds-mediated PA activity, you are already in the cross-PBM FWA pool whether or not the notice has arrived.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Recoupment Reversed
An independent pharmacy was caught up in a PBM FWA crackdown on CoverMyMeds prior-auth account activity. HLA reconstructed the full CoverMyMeds PA record and the PBM adjudication history, challenged the extrapolation methodology, and negotiated a final settlement substantially below the original demand.
Network Reinstated
A multi-location pharmacy received a PBM termination for cause tied to CoverMyMeds account patterns flagged in the FWA crackdown. HLA's appeal brief addressed each cited finding, documented the procedural record, addressed the platform-level account record, and returned the pharmacy to active network status.
State Board Closed
A PBM on-site audit (CoverMyMeds-driven) produced a state board of pharmacy referral alleging recordkeeping and dispensing violations. HLA's regulatory response addressed each cited deficiency and documented compliance with the state pharmacy practice act on the dispense dates; the board closed the matter with no discipline.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific audit.
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
Eight questions that come up on almost every first call.
Before you write a single page of your PBM response, have a privileged conversation with attorneys who have defended CoverMyMeds-driven matters across Express Scripts, OptumRx, and CVS Caremark. Free, confidential, no retainer.
